Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Apply zero based budgeting to household expenses to ensure every dollar is assigned, reducing waste and boosting savings.
18,110 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Policy moves hailed by industry leaders collide with technical realities. This article explains why trump's quantum p...
Ray Dalio wraps a 10-day China-focused Asia tour, warning that a realignment of global power could reshape markets an...
As AI reshapes manufacturing and logistics, the ROBO ETF is gaining attention for its diversified approach to robotic...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
The energy sector is flashing bright red this year as crude prices recover and producers benefit. This guide dives in...
Micron sits at the crossroads of AI demand, data-center spending, and cyclical memory trends. This guide explains why...
The S&P 500 closed near a decisive support level, raising the specter of additional losses if buyers fail to defend. ...
When apple stock fell today, traders raced to understand whether it signaled a broader shift in tech demand or a temp...
Polestar is barred from selling new cars in the United States under a new connected-vehicle rule, a move analysts say...
A brookings paper just accidentally released ties county AI exposure to voting shifts, offering a new lens on New Yor...
ServiceNow sprinted higher on Friday as AI and automation headlines fueled optimism. This piece breaks down the catal...